Microsoft word - engl cv-2.doc

Prof. Dr. med. Ulrich Hegerl Klinik und Poliklinik für Psychiatrie Universität Leipzig Semmelweisstraße 10 04103 Leipzig
1973-1978 University of Erlangen, Erlangen, Germany (Medicine)
Freie Universität, Berlin, Germany (Psychiatry, Neurology) Freie Universität, Berlin, Germany (Psychotherapy)
Positions and Employment
1977-1978 Medical internship, University Hospital, Rennes, France
1979-1980 Military physician (required service) Bayreuth, Germany
1980-1989 Residency and fellowships in the Department of Neurology, the
Department of Clinical Psychophysiology, the Department of Clinical Psychiatry, the Laboratory of Clinical Psychophysiology, and the Laboratory of Clinical Psychopharmacology, Freien Universität, Berlin, Germany 1986-1994 Resident, senior resident and supervising psychiatrist, Berlin Lithium 1994-1998 Supervising psychiatrist in various divisions: Depression Unit, Geriatric Unit, Relapse Prevention of Affective Disorders (Outpatient), Obsessive-Compulsive Disorders Clinic (Outpatient), Psychiatric Clinic of Ludwig-Maximilians-University, Munich, 1995-2006 Head of Clinical Neurophysiology, Ludwig-Maximilians-University, 1998-2006 Professor of Psychiatry, Psychiatric Clinic, Ludwig-Maximilians- Head of the German Research Network on Depression and Suicidality Head of the European Alliance Against Depression ( Chair and Medical Director of the Department of Psychiatry, Leipzig University, Leipzig, Germany Head of European research project “Optimized suicide preventive programme and its implementation in Europe“ (OSPI, 7th Framework Programme of the European Commission) Scientific field
• Supply oriented research • Suicide-prevention • Brain-function-diagnostics via EEG and EKP in combination with MRT, • Manumotoric and mimic of psychiatric patients • Biological correlates of Obsessive Compulsive Disorders (OCD) • Psycho- and pharmacotherapy of minor and subdiagnostic depression
2003 Clinic Promotion Award 2002 of the Bavarian Federal State Bank for
the project: „Nuremberg Alliance against Depression“ 2003 Hermann-Simon-Award for Social Psychiatry for the project: „Nuremberg Alliance against Depression“ 2007 „European Health Award“ (1st price) for the project „European Alliance
Qualified research projects of the last three years

Project title
term granted
2009 15.800 T€
2009 1.760 T€
2010 300 T€
the frame of KompAQT – Competence Network for work, qualification and transfer Endowed Professorship „Neurology of 2014 640 T€
Ulrich Hegerl Simon-Stiftung affective disorders“, (announced for 2014 2.996 T €
programme and its implementation in Europe (OSPI)
• European College of Neuropsychopharmacology (ECNP) • Collegium Internationale Neuro-Psychopharmacologicum (CINP) • Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmapsychiatrie (AGNP) (Working group of Neuropsychopharmakology • Deutsche Gesellschaft für Psychiatry, Psychotherapie und Nervenheilkunde (DGPPN) (German Association of Psychiatry, Psychotherapy and Neurology) • Deutsche Gesellschaft für Klinische Neurophysiologie (German Association • International Pharmaco-EEG Society (IPEG) • Hirnliga e.V. • Alzheimer´s Disease International
1985 Further educational stay with Prof. Dr. P. Watzlawik at the Mental Research
Institute (Palo Alto, “Brief Family Therapy”) 1990 Additional title “Psychotherapy” (Psychoanalytic oriented therapy)
Scientific stays
1986 Four week scientific stay with Prof. Dr. H. Maturana in his laboratory for
experimental neurophysiology at the Facultad de Ciencias of the Universidad de Chile (Santiago) 1990 Three week scientific stay with Prof. Dr. A. Gevins at the EEG Systems
Advisory Board
• Magazine “Neuropsychobiology” • Magazine “Pharmacopsychiatry” • Magazine “Psychopharmakotherapie”
EU and WHO activities
• Member of the WHO Task Force “Depression and stress-related disorders” • Member of the WHO/Euro Multicenter Study on Parasuicide • Member of the EU-commission of experts for the publicity of the topic “The economic and social burden of mental health and stress related diseases in the EU” concerning the “Community action in the field of public health” (2003-2008) • Member at the WHO-project “Mental Disorders in Primary Care” • Consultant of the European Commission - concerning the program “Quality of life and management of living resources”, domain 10: “Public Health” - concerning the program “Quality of life and management of living resources”, domain 9.3: “Brain development, disorders and repair and their clinical, epidemiological and social implications” as well as 9.4: “Behavior, cognition and functional mapping of the brain” - concerning the 6th Framework Program: “Life, Science, Health”.
Ten publications since 2003
Hegerl U, Mergl R, Henkel V, Gallinat J, Kotter G, Muller-Siecheneder F, Pogarell
O, Juckel G, Schroter A, Bahra R, Emir B, Laux G, Moller HJ. Kinematic analysis
of the effects of donepezil hydrochloride on hand motor function in patients with
Alzheimer dementia. Journal of Clinical Psychopharmacology. 2003;23:214-216.
Henkel V, Mergl R, Kohnen R, Maier W, Möller HJ, Hegerl U: Identifying depression in primary care: a comparison of different methods. BMJ 2003; 326: 200-201. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G, Folkerts M, Chouker M, Riedel M, Zaudig M, Moller HJ, Hegerl U. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology. 2004;29:1910-1917. Hegerl U, Mergl R, Henkel V, Pogarell O, Muller-Siecheneder F, Frodl T, Juckel G. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression. Psychopharmacology. 2005;178:58-66. Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A, Hegerl U, Lonnqvist J, Malone K, Marusic A, Mehlum L, Patton G, Phillips M, Rutz W, Rihmer Z, Schmidtke A, Shaffer D, Silverman M, Takahashi Y, Varnik A, Wasserman D, Yip P, Hendin H. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064-2074. Mulert C, Jager L, Propp S, Karch S, Stormann S, Pogarell O, Moller HJ, Juckel G, Hegerl U. Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI. NeuroImage. 2005;28:49-58. Hegerl U, Althaus D, Schmidtke A, Niklewski G. The Alliance against Depression: two year evaluation of a community based intervention to reduce suicidality. Psychol Med. 2006;36:1225-1234. Mulert C, Juckel G, Giegling I, Pogarell O, Leicht G, Karch S, Mavrogiorgou P, Moller HJ, Hegerl U, Rujescu D. A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials. Neuropsychopharmacology. 2006;31:1335-1344. Mulert C, Leicht G, Pogarell O, Mergl R, Karch S, Juckel G, Moller HJ, Hegerl U. Auditory cortex and anterior cingulate cortex sources of the early evoked gamma-band response: relationship to task difficulty and mental effort. Neuropsychologia. 2007;45:2294-2306. Pogarell O, Juckel G, Norra C, Leicht G, Karch S, Schaaff N, Folkerts M, Ibrahim A, Mulert C, Hegerl U. Prediction of clinical response to antidepressants in patients with depression: neurophysiology in clinical practice. Clin EEG Neurosci. 2007;38:74-77.


Microsoft word - final abbreviated tue form french

CCES Canadian Centre for Ethics in Sport Be true to yourself. Be true to your sport. Centre canadien pour l’éthique dans le sport Respecter son sport, c’est se respecter soi-même. 202-2197 promenade Riverside Drive, Ottawa, Ontario K1H 7X3 Canada Tel./Tél. 613.521.3340 Fax/Téléc. 613.521.3134 InfoLine 1.800.672.7775 Autorisation d’usage à des fins thérapeutiques : Proces


LAM-TUDOMÁNY • TOVÁBBKÉPZÉS • ÖSSZEFOGLALÓ KÖZLEMÉNY A vizeletinkontinenciagyógyszeres kezelésePHARMACOLOGICAL TREATMENTOF URINARY INCONTINENCEOne of the forms of conservative treatment ofincontinent patients is pharmacological therapy. Az inkontinens betegek konzervatív kezelésénekThe choice of medicine for the conservative treat-egyik formája a gyógyszeres terápia. Az

© 2010-2017 Pharmacy Pills Pdf